The price of Warrior Met Coal Inc (NYSE: HCC) closed at $68.22 in the last session, up 8.60% from day before closing price of $62.82. On the day, 1225922 shares were traded.
Ratios:
We take a closer look at HCC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.24. For the most recent quarter (mrq), Quick Ratio is recorded 5.87 and its Current Ratio is at 7.11. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on April 11, 2024, Upgraded its rating to Buy and sets its target price to $75 from $60 previously.
On January 16, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $68.
B. Riley Securities Upgraded its Neutral to Buy on September 23, 2022, whereas the target price for the stock was revised from $48 to $50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 23 ’24 when SCHUMACHER ALAN H bought 2,000 shares for $58.15 per share. The transaction valued at 116,300 led to the insider holds 30,270 shares of the business.
Williams Stephen D. sold 80,000 shares of HCC for $3,648,000 on Nov 08 ’23. The Director now owns 21,393 shares after completing the transaction at $45.60 per share. On Sep 13 ’23, another insider, Chopin Brian M, who serves as the Chief Accounting Officer of the company, sold 2,816 shares for $45.00 each. As a result, the insider received 126,720 and left with 11,187 shares of the company.
Valuation Measures:
As of this moment, Warrior’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.42, and their Forward P/E ratio for the next fiscal year is 10.71. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.13 while its Price-to-Book (P/B) ratio in mrq is 1.89.
Stock Price History:
Over the past 52 weeks, HCC has reached a high of $69.36, while it has fallen to a 52-week low of $31.69.
Shares Statistics:
A total of 52.02M shares are outstanding, with a floating share count of 51.38M. Insiders hold about 1.75% of the company’s shares, while institutions hold 92.28% stake in the company.
Earnings Estimates
The company has HCA Healthcare, Inc. analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $9.92, with high estimates of $26.41 and low estimates of $23.66.
Analysts are recommending an EPS of between $Basic Materials and $Technology for the fiscal current year, implying an average EPS of $Financial Services.
